BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24481866)

  • 21. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
    Hoffmann TK; Sonkoly E; Homey B; Scheckenbach K; Gwosdz C; Bas M; Chaker A; Schirlau K; Whiteside TL
    Head Neck; 2007 May; 29(5):472-8. PubMed ID: 17111427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum prognostic biomarkers in head and neck cancer patients.
    Lin HS; Siddiq F; Talwar HS; Chen W; Voichita C; Draghici S; Jeyapalan G; Chatterjee M; Fribley A; Yoo GH; Sethi S; Kim H; Sukari A; Folbe AJ; Tainsky MA
    Laryngoscope; 2014 Aug; 124(8):1819-26. PubMed ID: 24347532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study.
    Sakhi AK; Russnes KM; Thoresen M; Bastani NE; Karlsen A; Smeland S; Blomhoff R
    BMC Cancer; 2009 Dec; 9():458. PubMed ID: 20025747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.
    Peter F; Wittekindt C; Finkensieper M; Kiehntopf M; Guntinas-Lichius O
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):171-8. PubMed ID: 23007690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of recombinant GM-CSF on IL-6 and TNF-alpha levels in epithelial ovarian cancer patients who received paclitaxel and cisplatinum: preliminary results.
    Oktem M; Dilek TU; Guner H; Tiras MB
    Eur J Gynaecol Oncol; 2004; 25(4):478-80. PubMed ID: 15285308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
    Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
    Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma.
    Alhamarneh O; Agada F; Madden L; Stafford N; Greenman J
    Head Neck; 2011 Mar; 33(3):415-23. PubMed ID: 20645289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.
    Arthur AE; Peterson KE; Shen J; Djuric Z; Taylor JM; Hebert JR; Duffy SA; Peterson LA; Bellile EL; Whitfield JR; Chepeha DB; Schipper MJ; Wolf GT; Rozek LS
    Cancer; 2014 Sep; 120(17):2704-12. PubMed ID: 24830761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of TNF-alpha as a survival prognostic marker in chronic lymphocytic leukemia patients.
    Singer MK; Assem M; Abdel Ghaffar AB; Morcos NY
    Egypt J Immunol; 2011; 18(1):51-60. PubMed ID: 23082480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative and postoperative cytokines in patients with cancer.
    Nakazaki H
    Cancer; 1992 Aug; 70(3):709-13. PubMed ID: 1320454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma?
    Demirci U; Coskun U; Sancak B; Ozturk B; Bahar B; Benekli M; Buyukberber S
    Asian Pac J Cancer Prev; 2009; 10(6):1021-4. PubMed ID: 20192576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614.
    Koch WM; Ridge JA; Forastiere A; Manola J
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):851-8. PubMed ID: 19770416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
    Pradhan-Palikhe P; Vesterinen T; Tarkkanen J; Leivo I; Sorsa T; Salo T; Mattila PS
    Oral Oncol; 2010 Jul; 46(7):514-8. PubMed ID: 20371206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein levels: a prognostic marker for patients with head and neck cancer?
    Kruse AL; Luebbers HT; Grätz KW
    Head Neck Oncol; 2010 Aug; 2():21. PubMed ID: 20673375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma.
    Skrinjar I; Brailo V; Vidovic-Juras D; Vucicevic-Boras V; Milenovic A
    Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e402-7. PubMed ID: 25858079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
    Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.